A further grant has been made to Dr Ashley Vardon, NIHR Academic Clinical Lecturer, Institute of Cancer and Genomic sciences, University of Birmingham. DIPG Neurospheres - Image: University of Birmingham Recently, CAR T-cell therapy has emerged as a treatment option for diffuse midline glioma (DMG) including diffuse intrinsic pontine glioma (DIPG). After treatment some patients with H3 K27M-mutated DMG benefited from clinical and neurological improvements, and reduced tumour

This research project 'Exploiting the potential of protons and high-LET radiation in Diffuse Midline Glioma' aims to investigate new...

J azz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant...

A small project grant to generate pre-clinical data has been made to: Dr Ashley Vardon, NIHR Academic Clinical Lecturer, Institute of...

The Thirteenth Paediatric Strategy Forum focused on finding better treatments for children and young people with diffuse midline glioma...

CAR-T study targeting IL-13RA2 for paediatric-type diffuse high-grade gliomas including diffuse midline glioma Dr. Karin Straathof:...

Some encouraging and very inspiring news from the Monje lab and CAR-T cell therapy trials at Stanford Medicine. Photo : Stanford News....

Abbie’s Army has joined the DIPG/DMG Collaborative as Leadership Partners